BRESCHI, G. L.; DEMMA, F.; MORELLI, P.; DE FRANCESCO, M. Brentuximab vedotin in adult patients with HL CD30+ at high risk of relapse or progression following ASCT: a cost-analysis in Italy. AboutOpen, [S. l.], v. 8, n. 1, p. 81–87, 2021. DOI: 10.33393/ao.2021.2263. Disponível em: https://journals.aboutscience.eu/index.php/aboutopen/article/view/2263. Acesso em: 18 apr. 2024.